Aurinia Pharmaceuticals Cash Flow Statement (2015-2026) | AUPH

Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-47.01M-50.26M-33.32M-37.63M-35.52M-8.99M-26.02M-26.21M-11.53M-13.45M-26.87M-10.75M0.72M14.31M1.48M23.35M21.51M31.55M210.75M34.35M
Depreciation and Depletion (Quarter)
0.20M0.20M-1.37M0.69M0.69M1.11M-1.89M0.72M0.72M5.26M-6.10M4.85M4.84M4.89M-13.98M
Share-based Compensation (Quarter)
7.75M7.09M8.58M7.02M10.05M8.32M6.90M9.47M12.27M11.81M11.77M5.74M8.59M8.33M8.95M-3.41M5.44M5.92M6.73M-0.87M
Deferred Taxes (Quarter)
9.28M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
0.36M5.58M-6.00M-1.37M-0.79M2.94M-0.78M0.02M11.90M11.90M8.34M2.80M3.20M-4.54M-1.46M8.93M6.20M-5.94M-0.28M-0.58M
Asset Writedowns and Impairment (Quarter)
0.24M1.18M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
-37.98M-40.25M-25.92M-46.75M-27.87M-15.36M10.45M-31.67M-2.83M-13.28M14.31M-18.60M15.84M17.03M30.11M1.30M44.24M44.45M45.67M32.56M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.50M0.50M-2.26M-0.14M-0.21M0.36M1.56M2.61M2.99M3.24M3.31M3.21M3.12M3.42M2.98M2.66M2.56M2.62M2.33M2.32M
Amortization of Deferred Charges (Quarter)
Amortization (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.20M0.20M-1.37M0.69M0.69M1.11M-1.89M0.72M0.72M5.26M-6.10M4.85M4.84M4.89M4.86M4.86M4.86M4.87M4.86M4.82M
Change in Working Capital
Change in Receivables (Quarter)
3.23M5.40M5.60M4.99M-2.23M23.60M-28.28M5.56M0.46M18.45M-13.86M4.82M-3.39M10.96M0.06M3.81M-0.26M-9.36M10.73M7.72M
Change in Inventory (Quarter)
1.44M1.92M0.28M6.94M1.01M0.51M0.61M6.99M1.41M0.58M6.88M0.06M-0.91M-0.14M0.51M6.97M0.31M-1.71M0.90M0.72M
Change in Account Payables (Quarter)
1.34M2.74M0.46M-3.69M-0.97M-0.90M-1.10M1.10M-0.65M
Change in Accured Expenses (Quarter)
8.13M0.12M2.93M-6.70M0.46M7.12M0.62M-4.12M5.36M10.57M0.34M-7.94M4.13M-0.33M17.47M-23.41M6.27M-0.64M13.12M-5.59M
Other Working Capital Changes (Quarter)
0.84M-0.03M4.84M-0.17M5.08M-1.45M-1.06M-3.59M1.21M5.26M0.87M-0.87M0.23M0.09M2.38M-6.03M11.18M-6.09M4.61M-0.21M
Investing Activities
Capital Expenditures (Quarter)
3.50M3.50M-0.90M0.08M0.04M0.04M0.13M0.35M0.18M-0.10M0.30M0.01M0.13M0.09M0.06M0.02M0.10M0.07M0.07M0.04M
Sales of Property, Plant and Equipment (Quarter)
Change in Intangibles (Quarter)
-0.01M0.16M0.05M0.03M0.01M0.08M0.13M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)
103.71M99.10M90.67M110.57M115.11M120.43M118.21M167.77M120.53M103.00M138.09M170.50M158.37M132.57M123.97M123.03M132.25M93.50M145.35M109.00M
Cash from Investing Activities (Quarter)
1.67M-32.81M-5.49M-53.02M45.62M-50.22M-3.02M24.86M-5.61M-19.70M-6.26M49.23M-38.62M-10.57M39.22M31.03M-13.27M-13.77M-36.76M-18.08M
Financing Activities
Cash from Financing Activities (Quarter)
1.28M9.08M205.72M0.41M1.34M0.69M1.64M1.14M-2.33M-5.58M-15.05M-8.27M-2.72M-23.05M-49.34M-44.39M-10.49M-1.89M-53.69M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-35.03M-63.97M174.31M-99.36M19.09M-65.58M8.12M-5.17M-7.29M-35.31M2.48M15.58M-31.05M3.73M46.29M-17.00M-13.43M20.19M7.02M-39.20M
Free Cash Flow (Quarter)
-41.48M-43.75M-25.03M-46.83M-27.91M-15.40M10.32M-32.02M-3.00M-13.17M14.01M-18.61M15.71M16.94M30.06M1.28M44.14M44.38M45.60M32.52M
Net Cash Flow (Quarter)
-35.03M-63.97M174.31M-99.36M19.09M-65.58M8.12M-5.17M-7.29M-35.31M2.48M15.58M-31.05M3.73M46.29M-17.00M-13.43M20.19M7.02M-39.20M